Skip to main content
SpringerLink
Log in

The evolving role for surgery in the management of nonseminomatous testicular carcinoma

  • Published:
World Journal of Urology Aims and scope Submit manuscript

Summary

Once the only therapy available for locoregional disease extension, the approriate role for surgical management by retroperitoneal lymphadenectomy (RPND) of nonseminomatous germ cell testicular cancer is now being redefined in an algorithm of management comprising several modalities. Nerve-sparing techniques for RPND have overcome a substantial hesitancy for its continued utilization. Its continued use in low stage disease provides both therapeutic and diagnostic benefit; its role in relation to surveillance protocols will be defined. For bulky disease, node dissection is best reserved after induction chemotherapy; the need for surgery after such chemotherapy will be reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Borge N, Fossa SD, Ous S, Stenwig AE, Lien HH (1988) Late recurrence of testicular cancer. J Clin Oncol 6:1248–1253

    Google Scholar 

  2. Bosl GJ, Geller NL, Bajorin D, Leitner SP, Yagoda A, Golbey RB, Scher H, Vogelzang NJ, Auman J, Carey R, Fair WB, Herr H, Morse M, Sogani P, Whitmore W Jr (1988) A randomized trial of etoposide+cisplatin versus vinblastine+bleomycin+cisplatin +cyclophosphamide+dactinomycin in patients with good-prognosis germ cell tumors. J Clin Oncol 6:1231–1238

    Google Scholar 

  3. DeLeo MJ, Greco FA, Hainsworth JD, Johnson DH (1988) Late recurrences in long-term survivors of germ cell neoplasms. Cancer 62:985–988

    Google Scholar 

  4. Dexeus FH, Shirkhoda A, Logathetis CJ, Chong C, Sella A, Ogden S, Swanson D (1989) Clinical and radiological correlation of retroperitoneal metastasis from nonseminomatous testicular cancer treated with chemotherapy. Eur J Cancer Clin Oncol 25:35–43

    Google Scholar 

  5. Donohue JP (1977) Retroperitoneal lymphadenectomy: the anterior approach including suprarenal hilar dissection. Urol Clin North Am 4:517–521

    Google Scholar 

  6. Donohue JP (1984) Lymphadenectomy in urologic cancers, part I. American Urological Association, Bellaire, TX (AUA Update series 3, lesson 36)

    Google Scholar 

  7. Donohue JP (1989) Testicular cancer, clinical stage I (Letter). Ann Intern Med 110:409–410

    Google Scholar 

  8. Donohue JP, Rowland RG (1981) Complications of retroperitoneal lymph node dissection. J Urol 125:338–340

    Google Scholar 

  9. Donohue JP, Rowland RG (1984) The role of surgery in advanced testicular cancer. Cancer 54:2716–2721

    Google Scholar 

  10. Donohue JP, Roth LM, Rowland RG, Zachary JM, Einhorn LH, Williams SG (1982) Cytoreductive surgery for metastatic testis cancer: tissue analysis of retroperitoneal masses after chemotherapy. J Urol 127:1111–1114

    Google Scholar 

  11. Donohue JP, Zachary JM, Maynard BR (1982) Distribution of nodal metastases in nonseminomatous testis cancer. J Urol 128:315–320

    Google Scholar 

  12. Donohue JP, Rowland RG, Kopecky K, Steidle CP, Geier G, Ney KG, Einhorn LH, Williams S, Loehrer P (1987) Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J Urol 137:1176–1179

    Google Scholar 

  13. Drasga RE, Einhorn LH, Williams SP, Patel DN, Stevens EE (1983) Fertility after chemotherapy for testicular cancer. J Clin Oncol 1:179–189

    Google Scholar 

  14. Dunnick NR, Javadpour N (1981) Value of CT and lymphography: distinguishing retroperitoneal metastases from nonseminomatous testicular tumours. AJR 136:1093–1099

    Google Scholar 

  15. Dunphy CH, Ayala AG, Swanson DA, Ro JY, Logothetis C (1988) Clinical stage I nonseminomatous and mixed germ cell tumors of the testis. Cancer 62:1202–1206

    Google Scholar 

  16. Einhorn LH, Williams SD, Mandelbaum I, Donohue JP (1981) Sugical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer 48:904–908

    Google Scholar 

  17. Fossa SD, Ous S, Abyholm T, Loeb M (1985) Post-treatment fertility in patients with testicular cancer: I. Influence of retroperitoneal lymph node dissection on ejaculatory potency. Br J Urol 57:204–209

    Google Scholar 

  18. Fossa SD, Ous S, Abyholm T, Norman N, Loeb M (1985) Post-treatment fertility in patients with testicular cancer: II Influence of cisplatin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production. Br J Urol 57:210–214

    Google Scholar 

  19. Fraley EE, Narayan P, Vogelzang NJ, Kennedy BJ, Lange PH (1985) Surgical treatment of patients with stage I and II nonseminomatous testicular cancer. J Urol 134:70–73

    Google Scholar 

  20. Freedman LS, Parkinson MC, Jones WG, Oliver RTD, Peckham MJ, Read G, Newlands ES, Williams DJ (1987) Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet II:294–297

    Google Scholar 

  21. Fritz K, Weissbach L (1985) Sperm parameters and ejaculation before and after operative treatment of patients with germ-cell testicular cancer. Fertil Steril 43:451–454

    Google Scholar 

  22. Fung CY, Garnick MG (1988) Clinical stage I carcinoma of the testis: a review. J Clin Oncol 6:734–750

    Google Scholar 

  23. Heiken JP, Balfe DM, McClennan BC (1984) Testicular tumors: oncologic imaging and diagnosis. Int J Radiat Oncol Biol Phys 10:275–287

    Google Scholar 

  24. Hoskin P, Dilly S, Easton D, Horwich A, Hendry W, Peckham MJ (1986) Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J Clin Oncol 4:1031–1036

    Google Scholar 

  25. Javadpour N, Moley J (1985) Alternative to retroperitoneal lymphadenectomy with preservation of ejaculation and fertility in stage I nonseminomatous testicular cancer. A prospective study. Cancer 55:1604–1606

    Google Scholar 

  26. Javadpour N, Ozols RF, Anderson T, Barlock AB, Wesley R, Young RC (1982) A randomized trial of cytoreductive surgery followed by chemotherapy versus chemotherapy alone in bulky stage III testicular cancer with poor prognostic features. Cancer 50:2004–2010

    Google Scholar 

  27. Jewett MAS, Kong Y-SP, Goldberg SD, Sturgeon JFG, Thomas GM, Alison RE, Gospodarowicz MK (1988) Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol 139:1220–1224

    Google Scholar 

  28. Labate JS (1938) The surgical anatomy of the superior hypogastric plexus-“presacral nerve”. Surg Gynecol Obstet 67:199–211

    Google Scholar 

  29. Lange PH, Fraley EE (1988) Controversies in the management of low volume stage II nonseminomatous germ cell testicular cancer. Semin Oncol 15:324–334

    Google Scholar 

  30. Lange PH, Narayan P, Fraley EE (1984) Fertility issues following therapy for testicular cancer. Semin Urol 2:264–274

    Google Scholar 

  31. Lange PH, Chang WY, Fraley EE (1987) Fertility issues in the therapy of nonseminomatous testicular tumors. Urol Clin North Am 14:731–747

    Google Scholar 

  32. Lewis LG (1948) Testis tumor: report on 250 cases. J Urol 59:763–772

    Google Scholar 

  33. Logothetis CJ, Samuels ML (1984) Surgery in the management of stage III germinal cell tumors. Observations on the M. D. Anderson Hospital experience, 1971–1979. Cancer Treat Rev II:27–37

    Google Scholar 

  34. Moriyama N, Daly JJ, Keating MA, Lin C-W, Prout GR Jr (1985) Vascular invasion as a prognosticator of metastatic disease nonseminomatous germ cell tumors of the testis. Importance in “surveillance only” protocols. Cancer 56:24922–24928

    Google Scholar 

  35. Moul JW, Robertson JE, George SL, Paulson DF, Walther PJ (1989) Complications of therapy for testicular cancer. J Urol 142:1491–1496

    Google Scholar 

  36. Newlands ES, Reynolds KW (1989) The role of surgery in metastatic testicular germ cell tumours (GCT) (Editorial). Br J Cancer 59:837–839

    Google Scholar 

  37. Peckham MJ, Hendry WF (1985) Clinical stage II nonseminomatous germ cell testicular tumours. Results of management by primary chemotherapy. Br J Urol 57:763–768

    Google Scholar 

  38. Pizzocaro G (1986) Retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germinal testis cancer. Eur J Surg Oncol 12:25–28

    Google Scholar 

  39. Pizzocaro G, Zanoni F, Salvioni R, Milani A, Piva L, Pilotti S (1987) Difficulties of a surveillance study omiting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis. J Urol 138:1393–1996

    Google Scholar 

  40. Raghavan D (1985) Orchiectomy alone for stage I nonseminomatous germ cell tumors. In Gernick MB (ed) Genitourinary cancer — contemporary issues in clinical oncology, vol 5. Churchill Livingstone, New York, pp 21–36

    Google Scholar 

  41. Raghavan D, Colls B, Levi J, Fitzharris B, Tattersall MHN, Atkinson C, Woods R, Coorey G, Farrell C, Wines R (1988) Surveillance for stage I non-seminomatous germ cell tumours of the testis: the optimal protocol has not yet been defined. Br J Urol 61:522–526

    Google Scholar 

  42. Ray B, Hajdu SI, Whitmore WF Jr (1974) Distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer 33:340–348

    Google Scholar 

  43. Skinner DG, Melamud A, Lieskovsky G (1982) Complications of thoracoabdominal retroperitoneal lymph node dissection. J Urol 127:1107–1110

    Google Scholar 

  44. Sogani PC, Fair SR (1988) Surveillance alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis (NSCGT). Semin Urol 6:53–56

    Google Scholar 

  45. Sogani PC, Whitmore WF Jr, Herr HW, Bosl GJ, Golbey RB, Watson RC, DeCosse JJ (1984) Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis. J Clin Oncol 2:267–270

    Google Scholar 

  46. Staubitz WJ, Magoss IV, Grace JT, Schenk WGIII (1969) Surgical management of testis tumors. J Urol 101:350–355

    Google Scholar 

  47. Stephens RL, Williamson SK (1988) Clinical stage I testicular cancer; orchiectomy without node dissection (Editorial) Ann Intern Med 109:179–181

    Google Scholar 

  48. Tait D, Peckham MJ, Hendry WF, Goldstraw P (1984) Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer 50:601–609

    Google Scholar 

  49. Ulbright TM, Loehrer PJ, Roth LM, Einhorn LH, Williams SD, Clark SA (1984) The development of non-germ cell malignancies within germ cell tumors: a clinicopathologic study of 11 cases. Cancer 54:1824–1833

    Google Scholar 

  50. Vugrin D, Whitmore WF Jr (1985) The role of chemotherapy and surgery in the treatment of retroperitoneal metastases in advanced nonseminomatous testis cancer. Cancer 55:1874–1878

    Google Scholar 

  51. Vugrin D, Whitmore WF Jr, Sogani PC, Bains M, Herr HW, Golbey RB (1981) Combined chemotherapy and surgery in treatment of advanced germ cell tumors. Cancer 47:2228–2231

    Google Scholar 

  52. Walsh PC, Kaufman JJ, Coulson WF, Goodwin WE (1971) Retroperitoneal lymphadenectomy for testicular tumors. JAMA 217:309–312

    Google Scholar 

  53. Whitelaw GP, Smithwick RH (1951) Some secondary effects of sympathectomy — with particular reference to disturbance of sexual function. N Engl J Med 245:121–130

    Google Scholar 

  54. Williams SD, Stablein DM, Einhorn LH, Muggia FM, Weiss RB, Donohue JP, Paulson DF, Brunner KW, Jacobs EM, Spaulding JT, DeWys WD, Crawford ED (1987) Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. New Engl J Med 317:1433–1438

    Google Scholar 

  55. Yeager JH, Crowley RA (1948) Anatomical observations on lumbar sympathetics with evaluation sympathectomies in organic peripheral vascular disease. Ann Surg 127:853–867

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Surgery (Urology) and Experimental Pathology, Duke University School of Medicine and Comprehensive Cancer Center, Box 3314, 27710, Durham, NC, USA

    Philip J. Walther

Authors
  1. Philip J. Walther
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walther, P.J. The evolving role for surgery in the management of nonseminomatous testicular carcinoma. World J Urol 8, 13–19 (1990). https://doi.org/10.1007/BF01576272

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01576272

Keywords

Search

Navigation